07 jun ,2018

Pivot Park is one of the fastest growing campuses in the Netherlands

With a growth of 57% in employment between 2014 and 2018, Pivot Park is one of the fastest growing campuses in the Netherlands. This became evident from a recently published report by Buck Consultants International. The researchers conclude that things are going well with the campuses in the Netherlands. They are a popular location and […]

14 mrt ,2018

Ardena Group acquires ChemConnection

We are pleased to announce that ChemConnection has become part of the Ardena Group.  Joining Ardena enables us to become your one source contractor for all chemical, pharmaceutical and (bio)analytical needs that arise in the clinical supply chain. We believe that by joining forces, substantial benefits will be created, reducing your project risks and shortening […]


Older news

07 dec ,2017

Spago Nanomedical select ChemConnection for SpagoPix production to supply clinical trials

Spago Nanomedical AB has signed an agreement with ChemConnection BV, a well-established contract manufacturer with extensive experience in the GMP-production of nanomedical products, for the manufacture of the SpagoPix product candidate SN132D for clinical trials. Click here for press release.

Further reading >
06 sep ,2016

Austin Chemical Company, Syncom, and ChemConnection announce partnership and establish joint venture SynConnection LLC

BUFFALO GROVE (IL, USA), GRONINGEN (The Netherlands), OSS (The Netherlands), 6 September 2016 – Austin Chemical Company Inc, a pharmaceutical procurement and logistics service provider announced today the joint venture with Syncom BV, a pharmaceutical contract synthesis company, and ChemConnection BV, a GMP licensed contact manufacturing company. The development of novel active pharmaceutical ingredients (NCEs, […]

Further reading >
16 jun ,2016


Oss and Maastricht, The Netherlands, June 1, 2016 – ChemConnection, a privately-held company manufacturing nanomedicines, bioconjugates, peptides, and small molecules, announces the successful GMP production of CriPec® docetaxel for its customer Cristal Therapeutics, a privately-held life sciences company developing nanomedicines against cancer and other diseases. “ChemConnection has made a tremendous leap forward in becoming the […]

Further reading >
26 jan ,2016

Renewal GMP license

January 21, ChemConnection was audited by the Dutch health authorities (IGZ). The audit was very successful and has resulted in the renewal of the GMP manufacturing license for API and bulk drug product. With the licenses in place, ChemConnection continues its leading role in nanomedicine development and manufacturing

Further reading >
12 nov ,2015

ChemConnection is hiring

ChemConnection has a job vacancy for an early stage researcher (PhD candidate) for the NANOMED European Training Network. The application deadline is November 23, 2015. Please download the job description for a detailed overview of this vacancy.

Further reading >
07 okt ,2015

ChemConnection present at BioEurope 2015

ChemConnection will be present at the autumn edition of BioEurope in Munich, November 2015. Please contact us via the partnering network, or send us an email message to organize an appointment. ChemConnection will be represented by our scientific advisor nanomedicines Dr. Marcel van der Sluis.

Further reading >
26 mei ,2015

Horizon2020 Program

Horizon2020 program for Bio-Organic Chemistry group of the Radboud University Nijmegen, The Netherlands The bio-organic chemistry group of the Institute for Molecules and Materials (IMM) of the Radboud University Nijmegen, The Netherlands, has been awarded a 3.9 M€ ITN consortium on nanomedicine from the Horizon2020 program. Under supervision of the IMM a special training program […]

Further reading >
29 apr ,2015

New Website

Spring is here and all flowers are blooming. We thought this is the moment to launch or brand new website. With this site we will be able to update you with the latest information about ChemConnection. We need to add some more content, but that will completed soon. Hope you like it.

Further reading >
class="last-menu-item menu-itemve-menu" class="">
  • Drug Substances
  • Nanomedicines
  • Analytical Sciences
  • About us
  • Contact